Company Description
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications.
The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample.
It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas.
The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
| Country | United States |
| Founded | 2012 |
| IPO Date | Dec 18, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 172 |
| CEO | Kevin Knopp |
Contact Details
Address: 44 3rd Avenue Burlington, Massachusetts 01803 United States | |
| Phone | 857-254-1500 |
| Website | 908devices.com |
Stock Details
| Ticker Symbol | MASS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $20.00 |
| CIK Code | 1555279 |
| CUSIP Number | 65443P102 |
| ISIN Number | US65443P1021 |
| Employer ID | 45-4524096 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Dr. Kevin J. Knopp Ph.D. | Co-Founder, Chief Executive Officer, President and Director |
| Dr. Christopher David Brown Ph.D. | Co-Founder, Board Advisor and Director |
| Joseph H. Griffith IV | Chief Financial Officer and Treasurer |
| Mark S. Levine J.D. | Chief Legal and Administrative Officer |
| Barbara Russo | Vice President of Marketing and Corporate Communications |
| Don Osmer | Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 13, 2026 | EFFECT | Notice of Effectiveness |
| Mar 9, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Mar 9, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 9, 2026 | 10-K | Annual Report |
| Mar 3, 2026 | 8-K | Current Report |
| Feb 17, 2026 | SCHEDULE 13G/A | Filing |
| Feb 9, 2026 | SCHEDULE 13G | Filing |
| Jan 20, 2026 | 8-K | Current Report |
| Dec 5, 2025 | SCHEDULE 13G/A | Filing |
| Nov 14, 2025 | SCHEDULE 13G | Filing |